Last reviewed · How we verify
NCT05776095
Evaluation of Safety and Performance Outcomes of Eyedeal IOL Implantation After Cataract Removal
NA trial testing Cataract surgery in Lens Implantation, Intraocular in 97 participants. Status unknown.
28 February 2025
Quick facts
| Lead sponsor | Xi'an Eyedeal Medical Technology Co., Ltd |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 97 |
| Start date | 10 November 2023 |
| Primary completion | 28 February 2025 |
| Estimated completion | 28 February 2025 |
| Sites | 2 locations across Lithuania, Germany |
Drugs / interventions tested
- Cataract surgery — full drug profile →
- Eyedeal® Model PX65AS1 IOL
Conditions studied
- Lens Implantation, Intraocular — all drugs for Lens Implantation, Intraocular →
Sponsor
Xi'an Eyedeal Medical Technology Co., Ltd
Who can join
22 and older, any sex, with Lens Implantation, Intraocular. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A cataract is the clouding of the natural lens in the eye and is very common as when getting older. A cloudy lens makes it difficult to see. A cataract is treated by removing the cloudy lens and replacing it with an intraocular lens (known as an IOL). The goal of this clinical trial is to determine if the Eyedeal® IOL can be safely implanted in a subject's eye and if it can replace efficiently the natural lens. Subjects will be asked to attend a total of seven visits for this study for a period of 12 months after surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05776095
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cataract surgery
Trials testing the same drug.
- NCT06505434 — A Dynamic Study of Pupil Diameter After Artificial Lens Implantation in Patients With High Myopia · not yet recruiting
- NCT06400745 — Clareon PanOptix Pro vs. Clareon PanOptix - Study A · NA · completed
- NCT05796674 — Clareon IOL Retrospective Data Collection · completed
- NCT04074954 — A (Prospective/Pilot) Study Evaluating the Effect of Cataract Surgery on the Daily Activity Levels of Elderly Patients · withdrawn
- NCT06600945 — Atracurium Versus Atracurium and Magnesium Sulphate As Adjuvants to Local Anesthetic · recruiting
Other recruiting trials for Lens Implantation, Intraocular
Currently open trials in the same condition.
- NCT05136950 — Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05776095 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xi'an Eyedeal Medical Technology Co., Ltd
- Last refreshed: 2 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05776095.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing